Ro Sparks review: is it worth it?

What is Ro Sparks, and who makes it?

Ro Sparks is a product of Ro (Roman Health Ventures), one of the largest direct-to-consumer telehealth companies in the United States. Ro does not manufacture Sparks itself in the way a pharmaceutical company makes Viagra. Instead, Sparks is a compounded medication: a custom formulation mixed by a licensed compounding pharmacy that Ro works with, then dispensed only to customers a Ro-affiliated clinician has evaluated and prescribed it to.

The product is a small troche or lozenge placed under the tongue, where it dissolves over roughly ten minutes. Each dose contains both sildenafil (commonly reported at about 50 mg) and tadalafil (about 22 mg) in one tablet. That pairing is the entire pitch: sildenafil for fast onset and tadalafil for long duration, delivered sublingually rather than swallowed.

The single most important fact about Ro Sparks is its regulatory status. Brand-name Viagra and Cialis, and their standard generics, are FDA-approved drugs whose exact formulations have been reviewed for safety, efficacy, and manufacturing quality. Ro Sparks is not an FDA-approved product. As a compounded drug made under Section 503A of the Federal Food, Drug, and Cosmetic Act, its specific formulation is exempt from FDA pre-market approval and from current good manufacturing practice (CGMP) requirements that apply to mass-produced drugs (FDA, "Section 503A"). The active ingredients — sildenafil and tadalafil — are individually FDA-approved and have decades of data behind them; the combination, the dose, and the sublingual delivery as sold by Ro have not been independently studied or approved.

How does Ro Sparks work?

Both of its ingredients are phosphodiesterase type 5 (PDE5) inhibitors. Sexual stimulation triggers the release of nitric oxide in the penis, which raises levels of cyclic GMP, relaxing the smooth muscle of the corpora cavernosa and allowing blood to flow in and produce an erection. PDE5 is the enzyme that breaks down cyclic GMP. By blocking it, sildenafil and tadalafil let cyclic GMP accumulate, so an erection is easier to achieve and sustain in response to arousal (NIH, StatPearls). Neither drug causes an erection on its own — sexual stimulation is still required.

The reason Ro pairs two PDE5 inhibitors rather than one comes down to their different pharmacokinetics:

• Sildenafil acts relatively quickly and has a short half-life of roughly four hours, with clinical effect generally lasting four to six hours (Viagra FDA label).
• Tadalafil is slower to peak but has a long half-life of about 17.5 hours, which is why its branded version, Cialis, is marketed as the "weekend pill" with an effect window up to 36 hours (Cialis FDA label).

Combining them is intended to deliver sildenafil's faster onset together with tadalafil's extended duration. The sublingual format is marketed as speeding things up further: dissolving under the tongue is claimed to route some of the drug into the bloodstream through the oral mucosa rather than relying entirely on stomach and gut absorption, with Ro advertising an onset around 15 minutes. It is worth being precise here: there is limited published, peer-reviewed pharmacokinetic data confirming that this specific sublingual troche meaningfully outperforms a swallowed tablet, and a portion of any dissolved drug is still swallowed and absorbed through the gut. The onset and duration figures are best treated as marketing estimates, not trial-validated numbers.

How well does it actually work?

There is no clinical trial of Ro Sparks. That is the honest core of any evidence-based assessment: a compounded product is not required to demonstrate its own efficacy, and Ro Sparks has not. What we can say is grounded entirely in what is known about its two ingredients individually.

The efficacy of sildenafil is among the best-documented in all of urology. In the fixed-dose, placebo-controlled studies summarized in Viagra's prescribing information, 63%, 74%, and 82% of men reported improved erections at 25 mg, 50 mg, and 100 mg respectively, versus 24% on placebo (Viagra FDA label). The pivotal dose-response trial behind that approval was published in the New England Journal of Medicine (Goldstein et al., NEJM 1998; PMID 9580646). Tadalafil is similarly well supported, with large randomized trials showing significant improvement on the International Index of Erectile Function (IIEF) across its 5–20 mg as-needed range (Cialis FDA label).

Two cautions follow. First, because both drugs work, a combination will almost certainly "work" for most men who respond to either one — but that does not mean two drugs are better than one. There is no robust evidence that combining sildenafil and tadalafil produces better erections than an optimized single agent in someone who hasn't first failed monotherapy. Major urology guidance generally treats PDE5 inhibitors as interchangeable first-line options and does not recommend routinely stacking two of them. Second, the doses in Sparks are unusual. Sildenafil's standard as-needed range is 25–100 mg and tadalafil's as-needed range is 5–20 mg (with 2.5–5 mg for daily use). Roughly 50 mg of sildenafil plus 22 mg of tadalafil places both within their typical effective ranges simultaneously — meaning a user is exposed to a near-full dose of two PDE5 inhibitors at once, with the side-effect risks adding up accordingly.

What does the side-effect and safety profile look like?

Because Sparks delivers two PDE5 inhibitors together, the side effects are those of each drug, and the probability of experiencing them can stack. The most common are headache, flushing, nasal congestion, indigestion (dyspepsia), and muscle or back pain — the last being more associated with tadalafil. Sildenafil specifically can cause transient blue-green color vision changes (FDA labels for Viagra and Cialis).

More serious risks, though uncommon, are shared by the class:

• Hypotension. PDE5 inhibitors lower blood pressure. Two together amplify that effect, raising the chance of dizziness or fainting, especially when standing.
• Priapism. An erection lasting more than four hours is a medical emergency that can permanently damage penile tissue and requires immediate care.
• Sudden vision or hearing loss. Rare cases of non-arteritic anterior ischemic optic neuropathy (NAION) and sudden hearing loss have been reported with PDE5 inhibitors; either warrants stopping the drug and seeking care (FDA).

The most dangerous interaction is with nitrates — medications such as nitroglycerin, isosorbide mononitrate/dinitrate, and recreational "poppers" (amyl nitrite). Combining a PDE5 inhibitor with a nitrate can cause a profound, potentially fatal drop in blood pressure, and this combination is an absolute contraindication (FDA labels). PDE5 inhibitors must also be used cautiously with alpha-blockers (used for high blood pressure or an enlarged prostate) because of additive blood-pressure lowering, and with the pulmonary-hypertension drug riociguat, which is contraindicated. Men with significant cardiovascular disease, recent heart attack or stroke, severe liver or kidney impairment, very low or uncontrolled high blood pressure, or certain hereditary retinal disorders should generally avoid these drugs or use them only under close supervision.

A compounding-specific caveat: because the formulation is not made under FDA-overseen manufacturing standards, dose consistency and purity depend entirely on the quality controls of the specific compounding pharmacy. The FDA itself notes it is often unaware of problems with 503A-compounded products unless it receives an adverse-event complaint (FDA, "Compounding Inspections FAQ").

How is it prescribed and taken?

Ro Sparks is prescription-only and cannot be bought over the counter. The process is fully online: you complete an intake questionnaire about your health, medications, and symptoms; a licensed clinician reviews it (typically asynchronously rather than by live video); and, if appropriate, writes a prescription. The compounded medication is then prepared by the partner pharmacy, packaged discreetly, and shipped to your home, usually within several days.

To use it, the lozenge is placed under the tongue and allowed to dissolve rather than swallowed whole, ideally about 15 minutes before sexual activity. Because tadalafil persists for well over a day, a key dosing rule is not to redose frequently — taking another Sparks (or any other PDE5 inhibitor) within 24–36 hours risks accumulating drug levels and compounding side effects. Heavy alcohol use should be avoided, as it adds to the blood-pressure-lowering and dizziness effects.

What does it cost, and is it good value?

On Ro's monthly plans, Sparks is priced at roughly $12 per dose, with monthly totals scaling by quantity — commonly cited in the range of about $48 for four doses up to roughly $120 for ten. Quarterly prepaid plans shave a few dollars off, bringing the per-dose price down toward the high-$10 to ~$11 range depending on quantity. There is no insurance involved; this is cash-pay.

On value, the honest verdict is unfavorable. Ro Sparks is widely reported as one of the most expensive sildenafil-plus-tadalafil sublingual combos on the market. The reason this matters is that the same two active ingredients are available far more cheaply:

• Generic sildenafil (the chemical in Viagra) and generic tadalafil (the chemical in Cialis) are both inexpensive when prescribed individually and filled at a standard pharmacy — often a few dollars per dose or less with a discount card, especially generic tadalafil for daily use.
• Competing telehealth combos use the same ingredient pair at a lower price; Hims' "Hard Mints," for example, are a comparable sildenafil-plus-tadalafil compounded chewable whose per-dose price on most plans runs well below Sparks (Hims advertises tiers starting under a few dollars per chew, though the exact figure depends on the formulation and subscription term).

You are paying a premium primarily for the convenience, branding, and the single-lozenge sublingual format — not for any proven clinical advantage.

How does it compare to the alternatives?

• Standard generic sildenafil or tadalafil (single drug): The evidence-based default. FDA-approved, trial-validated, and dramatically cheaper. Most men with ED respond well to one optimized agent and never need a combination. This is the first thing to try.
• Hims Hard Mints / BlueChew and other compounded combos: Same drug class, similar concept, generally lower price. These share Sparks' core limitation — they are also compounded and unstudied as combinations — but they cost less.
• Brand Viagra or Cialis: More expensive than generics but FDA-approved and manufactured to strict standards; the choice for those who prioritize the regulated original.
• Daily low-dose tadalafil (2.5–5 mg): For men who want spontaneity without timing a dose, a daily generic tadalafil regimen is FDA-approved, well-studied, and very inexpensive — a strong alternative to an on-demand combo for many users.

Where Sparks could plausibly make sense is a narrow case: someone who has genuinely tried single-agent PDE5 inhibitors, found one too short-acting and the other too slow, and specifically wants both effects in one fast-dissolving dose — and is willing to pay a premium and accept an unstudied combination to get it. That is a much smaller group than Ro's marketing implies.

The bottom line

Ro Sparks is a convenient, legitimately prescribed product built from two of the most effective and best-studied ED drugs in existence — and that ingredient pedigree is its strongest point. But it is sold at a premium for a compounded combination that has no trial of its own, an unverified efficacy edge over a single optimized drug, FDA-unapproved manufacturing, and the stacked side-effect and interaction risks of two PDE5 inhibitors taken together. For most men, the smarter starting point is a single, inexpensive, FDA-approved generic — sildenafil as needed, or daily tadalafil for spontaneity — prescribed and dose-adjusted by a clinician. Sparks is best reserved for the minority who have tried monotherapy, want the specific fast-and-long sublingual experience, and accept paying more for an unstudied formulation. Anyone with heart disease, anyone taking nitrates or alpha-blockers, and anyone who hasn't first ruled out treatable underlying causes of ED should not start here.